- Home
- AEMD vs BMRA Comparison
AEMD vs BMRA Comparison
Compare AEMD & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEMD
- BMRA
- Stock Information
- Founded
- AEMD 1984
- BMRA 1971
- Country
- AEMD United States
- BMRA United States
- Employees
- AEMD N/A
- BMRA N/A
- Industry
- AEMD Medical/Dental Instruments
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AEMD Health Care
- BMRA Health Care
- Exchange
- AEMD Nasdaq
- BMRA Nasdaq
- Market Cap
- AEMD 5.0M
- BMRA 5.9M
- IPO Year
- AEMD N/A
- BMRA N/A
- Fundamental
- Price
- AEMD $0.71
- BMRA $0.43
- Analyst Decision
- AEMD Strong Buy
- BMRA
- Analyst Count
- AEMD 1
- BMRA 0
- Target Price
- AEMD $7.00
- BMRA N/A
- AVG Volume (30 Days)
- AEMD 1.3M
- BMRA 21.2M
- Earning Date
- AEMD 02-12-2025
- BMRA 01-14-2025
- Dividend Yield
- AEMD N/A
- BMRA N/A
- EPS Growth
- AEMD N/A
- BMRA N/A
- EPS
- AEMD N/A
- BMRA N/A
- Revenue
- AEMD N/A
- BMRA $5,578,000.00
- Revenue This Year
- AEMD N/A
- BMRA N/A
- Revenue Next Year
- AEMD N/A
- BMRA N/A
- P/E Ratio
- AEMD N/A
- BMRA N/A
- Revenue Growth
- AEMD N/A
- BMRA 1.40
- 52 Week Low
- AEMD $0.24
- BMRA $0.24
- 52 Week High
- AEMD $1.85
- BMRA $1.35
- Technical
- Relative Strength Index (RSI)
- AEMD 51.85
- BMRA 48.88
- Support Level
- AEMD $0.62
- BMRA $0.53
- Resistance Level
- AEMD $0.78
- BMRA $0.72
- Average True Range (ATR)
- AEMD 0.06
- BMRA 0.13
- MACD
- AEMD -0.01
- BMRA -0.01
- Stochastic Oscillator
- AEMD 34.18
- BMRA 15.84
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.